NCT03628989

Brief Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset, Augmented Reality Headset) are more effective than the standard of care (i.e., no technology-based distraction) for decreasing anxiety and pain scores in pediatric patients undergoing various minor procedures (i.e lumbar punctures and cardiac catheterization). The anticipated primary outcome will be a reduction of overall cumulative medication and secondary outcomes include but are not limited to: physician satisfaction, discharge time, pain scores, anxiety scores, and procedure time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 31, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 11, 2023

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

5.1 years

First QC Date

July 31, 2018

Last Update Submit

September 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measure anxiety score

    Numerical anxiety scale (0-10), 0 being no anxiety and 10 being the worst imaginable anxiety

    Duration of procedure (usually no more than 2-4 hours)

Secondary Outcomes (4)

  • Parent and Child Satisfaction Questionnaire

    Duration of procedure (usually no more than 2-4 hours)

  • Virtual and Augmented Reality Feedback Survey

    Duration of procedure (usually no more than 2-4 hours)

  • Asses cumulative medication dosing and the duration of procedure

    Duration of procedure (usually no more than 2-4 hours)

  • Evaluation of Passive vs Active Interventions

    Duration of procedure (usually no more than 2-4 hours)

Other Outcomes (3)

  • Fear assessment

    Duration of procedure (usually no more than 2-4 hours)

  • Pain Assessment

    Duration of procedure (usually no more than 2-4 hours)

  • Procedural Compliance

    Duration of procedure (usually no more than 2-4 hours)

Study Arms (3)

Cardiac Cathertization Patients

EXPERIMENTAL

Participants will use technology based distraction during procedure.

Behavioral: Use of Virtual Technology

Allergy Patients

EXPERIMENTAL

Participants will use technology based distraction during procedure

Behavioral: Use of Virtual Technology

Procedure-Only Patients

NO INTERVENTION

Interventions

If parent and child consent to be in the study, the clinician will offer the use of one of the technologies: Virtual Reality (VR) headset or Augmented Reality (AR) headset. Active content includes video games, interactive avatars, and interactive experiences, while passive content includes video clips and movies. All patients will be offered the opportunity to use these technologies during their minor procedures if they meet eligibility criteria. Those who decline or who are switched over to the standard of care due to patient preference, health providers monitoring and assessment during the procedure will be noted in the database.

Allergy PatientsCardiac Cathertization Patients

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 17 and under
  • Able to consent or have parental consent
  • Undergoing minor procedures (i.e lumbar punctures, cardiac catheterization) at Lucile Packard Children's Hospital (LPCH) or Stanford Hospital facilities

You may not qualify if:

  • People who do not consent
  • Significant Cognitive Impairment
  • History of Severe Motion Sickness
  • Current Nausea
  • Seizures
  • Visual Problems
  • Non-English Speaking
  • Patients who clinically unstable or requires urgent/emergent intervention
  • (ASA) Physical status classification class 4 or higher
  • Patient or parental preference for General Anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucile Packard Children's Hospital Stanford

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Thomas J Caruso, MD, MEd

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Samuel Rodriguez, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 31, 2018

First Posted

August 14, 2018

Study Start

June 1, 2018

Primary Completion

June 30, 2023

Study Completion

July 11, 2023

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations